7-氟-1,5-萘啶-2(1h)-酮 | 959615-64-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 中文名称: 7-氟-1,5-萘啶-2(1h)-酮
• 英文名称: 7-fluoro-1,5-naphthyridin-2(1H)-one
• 英文别名: 7-fluoro-1H-1,5-naphthyridin-2-one
• CAS: 959615-64-6
• 化学式: C₈H₅FN₂O
• 分子量: 164.139
• InChiKey: UHBAZQRMLAHIPL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  42
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险性防范说明：
  P261,P280,P301+P312,P302+P352,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温、干燥且密封保存。

反应信息

• 作为反应物：
  描述：

  7-氟-1,5-萘啶-2(1h)-酮 在 水 、 sodium hydride 、 溶剂黄146 、 三氟乙酸 作用下， 以 氯仿 、 N,N-二甲基甲酰胺 为溶剂， 反应 26.58h， 生成 tert-butyl (1-(2-(7-fluoro-2-oxo-1,5-naphthyridin-1(2H)-yl)ethyl)piperidin-4-yl)carbamate
  参考文献：
  名称：

  NOVEL HETEROCYCLIC COMPOUND OR SALT THEREOF AND INTERMEDIATE THEREOF

  摘要：

  公开号：

  EP2022793B1
• 作为产物：
  描述：

  2,6-二氯-5-氟烟酸 在 甲酸 、 三丁基膦 、 叠氮磷酸二苯酯 、 palladium diacetate 、 sodium carbonate 、 溶剂黄146 、 三乙胺 、 三苯基膦 、 叔丁醇 作用下， 以 乙酸丁酯 为溶剂， 生成 7-氟-1,5-萘啶-2(1h)-酮
  参考文献：
  名称：

  A One-Pot Diazotation–Fluorodediazoniation Reaction and Fluorine Gas for the Production of Fluoronaphthyridines

  摘要：

  Several synthetic routes to 7-fluoro-2-methoxy-8-methyl-1,5-naphthyridine (1) are presented, and their suitability for scale-up is discussed. The way of introducing the fluorine atom is crucial. Early routes start from commercially available fluorinated building blocks or employ F+ reagents like Select Fluor and delivered up to 70 kg of 7-fluoro-2-methoxy-1,5-naphthyridine (18). To prepare for larger scales, the focus turned to the use of HF or elemental fluorine, both one of the cheapest sources of fluorine. The first method, a one-pot diazotation-fluorodediazoniation with 6-methoxy-1,5-naphthyridin-3-amine (9) in HF gave the fluorinated naphthyridine 18 in high yield and purity without isolation of the unstable diazonium salt, the latter being a severe drawback of the related Balz-Schiemann protocol. The second method relies on the use of fluorine gas for a surprisingly selective ortho-fluorination of 6-methoxy-1,5-naphthyridin-4-ol (10).

  DOI：

  10.1021/op500100b

文献信息

• [EN] NAPHTHYRIDIN-2 (1 H)-ONE COMPOUNDS USEFUL AS ANTIBACTERIALS<br/>[FR] COMPOSÉS NAPHTHYRIDINE-2(1H)-ONE UTILES COMME ANTIBACTÉRIENS
  申请人：GLAXO GROUP LTD

  公开号：WO2010081874A1

  公开（公告）日：2010-07-22

  Compounds of Formula (I) wherein substituents R1, R2 and R5 are as defined, and Ar represents substituted phenyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, thiazolyl, furanyl, imidazolyl and thiophenyl substituted by a hydroxyalkyl substituent and an optional other substituent; compositions containing them, their use in therapy, including their use as antibacterials, for example in the treatment of tuberculosis, and methods for the preparation of such compounds, are provided.

  式（I）中的化合物，其中取代基R1、R2和R5如定义，并且Ar代表被羟基烷基取代和可选其他取代基取代的取代苯基、吡啶基、吡啶并嗪基、嘧啶基、吡嗪基、噻唑基、呋喃基、咪唑基和噻吩基；包含它们的组合物，它们在治疗中的用途，包括它们作为抗菌剂的用途，例如在结核病治疗中的用途，以及这类化合物的制备方法。
• Novel N-Linked Aminopiperidine-Based Gyrase Inhibitors with Improved hERG and in Vivo Efficacy against <i>Mycobacterium tuberculosis</i>
  作者：Shahul Hameed P、Vikas Patil、Suresh Solapure、Umender Sharma、Prashanti Madhavapeddi、Anandkumar Raichurkar、Murugan Chinnapattu、Praveena Manjrekar、Gajanan Shanbhag、Jayashree Puttur、Vikas Shinde、Sreenivasaiah Menasinakai、Suresh Rudrapatana、Vijayashree Achar、Disha Awasthy、Radha Nandishaiah、Vaishali Humnabadkar、Anirban Ghosh、Chandan Narayan、V. K. Ramya、Parvinder Kaur、Sreevalli Sharma、Jim Werngren、Sven Hoffner、Vijender Panduga、C. N. Naveen Kumar、Jitendar Reddy、Mahesh Kumar KN、Samit Ganguly、Sowmya Bharath、Ugarkar Bheemarao、Kakoli Mukherjee、Uma Arora、Sheshagiri Gaonkar、Michelle Coulson、David Waterson、Vasan K. Sambandamurthy、Sunita M. de Sousa

  DOI：10.1021/jm500432n

  日期：2014.6.12

  value. We describe a novel class of N-linked aminopiperidinyl alkyl quinolones and naphthyridones that kills Mtb by inhibiting the DNA gyrase activity. The mechanism of inhibition of DNA gyrase was distinct from the fluoroquinolones, as shown by their ability to inhibit the growth of fluoroquinolone-resistant Mtb. Biochemical studies demonstrated this class to exert its action via single-strand cleavage

  DNA促旋酶是开发抗结核分枝杆菌药物的临床验证靶标（MTB）。尽管有希望将氟喹诺酮类药物（FQs）用作抗结核药物，但先前对FQs耐药的流行很可能会限制其临床价值。我们描述了一种新型的N-连接的氨基哌啶基烷基喹诺酮类和萘啶酮类，通过抑制DNA促旋酶活性杀死Mtb。DNA促旋酶的抑制机制与氟喹诺酮类截然不同，其抑制氟喹诺酮类抗性Mtb生长的能力证明了这一点。生化研究表明，该类化合物通过单链裂解而不是双链裂解发挥作用，如氟喹诺酮类药物所见。这些化合物对细胞外和细胞内的Mtb具有高度的杀菌作用。铅的优化导致鉴定了具有改善的口服生物利用度并降低了心脏离子通道负担的有效化合物。该系列化合物在各种结核病鼠模型中均有效。
• Compounds
  申请人：GLAXO GROUP LIMITED

  公开号：EP2080761A1

  公开（公告）日：2009-07-22

  Compounds of Formula (I), compositions containing them, their use in therapy, including their use as antibacterials, for example in the treatment of tuberculosis, and methods for the preparation of such compounds, are provided.

  公式（I）的化合物， 包含它们的组合物，它们在治疗中的使用，包括它们作为抗菌剂的使用，例如在结核病治疗中的使用，以及制备这类化合物的方法，均已提供。
• [EN] BRIDGED BICYCLIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS<br/>[FR] COMPOSÉS BICYCLIQUES PONTÉS POUR LE TRAITEMENT DES INFECTIONS BACTÉRIENNES
  申请人：KYORIN SEIYAKU KK

  公开号：WO2013003383A1

  公开（公告）日：2013-01-03

  Novel bridged bicyclic compounds are disclosed herein, along with their pharmaceutically acceptable salts, hydrates and prodrugs. Also disclosed are compositions comprising such compounds, methods of preparing such compounds and methods of using such compounds as antibacterial agents. The disclosed compounds, their pharmaceutically acceptable salts, hydrates and prodrugs, as well as compositions comprising such compounds, salts, hydrates and prodrugs, are useful for treating bacterial infections and associated diseases and conditions.

  本文披露了新型桥环双环化合物，以及它们的药用盐、水合物和前药。还披露了包含这些化合物的组合物，制备这些化合物的方法以及将这些化合物用作抗菌剂的方法。所披露的化合物、其药用盐、水合物和前药，以及包含这些化合物、盐、水合物和前药的组合物，可用于治疗细菌感染及相关疾病和症状。
• [EN] [4- (1-AMINO-ETHYL) -CYCLOHEXYL] -METHYL-AMINES AS ANTIBACTERIALS<br/>[FR] [4-(1-AMINO-ÉTHYL)-CYCLOHEXYL]-MÉTHYL-AMINES EN TANT QU'AGENTS ANTIBACTÉRIENS
  申请人：ASTRAZENECA AB

  公开号：WO2010055348A1

  公开（公告）日：2010-05-20

  The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof, to their use in the treatment of bacterial infections, and to their methods of preparation.

  本发明涉及式（I）化合物及其药用盐，以及它们在治疗细菌感染中的应用，以及它们的制备方法。